DrugDashboards

Cefdinir

Cefdinir · CEFDINIR MONOHYDRATE 250 mg/5mL · Powder, For Suspension · Oral · Teva Pharmaceuticals USA, Inc.

NDC 00093-4137-64 · 60 mL in 1 BOTTLE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. The price is down 15% over the past year, to $0.1195 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1195per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.9331per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Nov 2013Sep 2026$0.1195
155 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$74.61
Reported to Texas DSHS · 2026 annual filing · Teva Pharmaceuticals USA, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$2.1M
114,737 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for cefdinir (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA065332
TE code
AB
Approval date
May 4, 2007
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedFeb 26, 2013
    Teva Pharmaceuticals USA, Inc. — Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.

Manufacturers of Cefdinir (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsCEFDINIR 250 mg/5mLJul 15, 2026Sep 3, 2026
Direct RxCEFDINIR 250 mg/5mLJul 15, 2026Sep 3, 2026
NuCare Pharmaceuticals, Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 3, 2026
NuCare Pharmaceuticals,Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsCEFDINIR MONOHYDRATE 250 mg/5mLAug 26, 2026Sep 2, 2026
Ascend Laboratories, LLCCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Direct RxCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.CEFDINIR MONOHYDRATE 125 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CEFDINIR MONOHYDRATE 250 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.CEFDINIR 250 mg/5mLJul 15, 2026Sep 2, 2026
Proficient Rx LPCEFDINIR 125 mg/5mLJul 15, 2026Sep 2, 2026
Proficient Rx LPCEFDINIR MONOHYDRATE 250 mg/5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CEFDINIR MONOHYDRATE 250 mg/5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CEFDINIR MONOHYDRATE 125 mg/5mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.CEFDINIR 125 mg/5mLJul 15, 2026Aug 31, 2026
Proficient Rx LPCEFDINIR 250 mg/5mLJul 15, 2026Aug 31, 2026
A-S Medication SolutionsCEFDINIR 125 mg/5mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cefdinir — NDC 00093-4137-64," retrieved September 3, 2026, https://drugdashboards.com/drug/00093413764.

Free to cite with attribution — see how the data is put together.